A multiobjective AI model for LNP engineering enhances tissue-selective mRNA delivery
Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).
Google Scholar
Baden, L. R. et al. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. 384, 403–416 (2021).
Google Scholar
Adams, D. et al. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis. N. Engl. J. Med. 379, 11–21 (2018).
Google Scholar
Nasreen, S. et al. Effectiveness of COVID-19 vaccines against symptomatic SARS-CoV-2 infection and severe outcomes with variants of concern in Ontario. Nat. Microbiol. 7, 379–385 (2022).
Google Scholar
Hou, X., Zaks, T., Langer, R. & Dong, Y. Lipid nanoparticles for mRNA delivery. Nat. Rev. Mater. 6, 1078–1094 (2021).
Google Scholar
Vasileva, O., Zaborova, O., Shmykov, B., Ivanov, R. & Reshetnikov, V. Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics. Front. Pharmacol. 15, 1466337 (2024).
Google Scholar
Wittrup, A. et al. Visualizing lipid-formulated siRNA release from endosomes and target gene knockdown. Nat. Biotechnol. 33, 870–876 (2015).
Google Scholar
Kim, M. et al. Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver. Sci. Adv. 7, eabf4398 (2021).
Google Scholar
Qiu, M. et al. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis. Proc. Natl Acad. Sci. USA 119, e2116271119 (2022).
Google Scholar
Hosseini-Kharat, M., Bremmell, K. E. & Prestidge, C. A. Why do lipid nanoparticles target the liver? Understanding of biodistribution and liver-specific tropism. Mol. Ther. Methods Clin. Dev. 33, 101436 (2025).
Google Scholar
Akinc, A. et al. Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Mol. Ther. 18, 1357–1364 (2010).
Google Scholar
Jain, R. et al. MicroRNAs enable mRNA therapeutics to selectively program cancer cells to self-destruct. Nucleic Acid Ther. 28, 285–296 (2018).
Google Scholar
Ramishetti, S. et al. A combinatorial library of lipid nanoparticles for RNA delivery to leukocytes. Adv. Mater. 32, e1906128 (2020).
Google Scholar
Chen, J. et al. Combinatorial design of ionizable lipid nanoparticles for muscle-selective mRNA delivery with minimized off-target effects. Proc. Natl Acad. Sci. USA 120, e2309472120 (2023).
Google Scholar
Li, B. et al. Combinatorial design of nanoparticles for pulmonary mRNA delivery and genome editing. Nat. Biotechnol. 41, 1410–1415 (2023).
Google Scholar
Han, X. et al. In situ combinatorial synthesis of degradable branched lipidoids for systemic delivery of mRNA therapeutics and gene editors. Nat. Commun. 15, 1762 (2024).
Google Scholar
Peña, Á et al. Multicomponent thiolactone-based ionizable lipid screening platform for efficient and tunable mRNA delivery to the lungs. Commun. Chem. 8, 116 (2025).
Google Scholar
Isaac, I. et al. Tetrahydropyrimidine ionizable lipids for efficient mRNA delivery. ACS Nano 18, 29045–29058 (2024).
Google Scholar
Hamilton, A. G. et al. High-throughput in vivo screening identifies differential influences on mRNA lipid nanoparticle immune cell delivery by administration route. ACS Nano 18, 16151–16165 (2024).
Google Scholar
Kauffman, K. J. et al. Optimization of lipid nanoparticle formulations for mRNA delivery in vivo with fractional factorial and definitive screening designs. Nano Lett. 15, 7300–7306 (2015).
Google Scholar
Ly, H. H., Daniel, S., Soriano, S. K. V., Kis, Z. & Blakney, A. K. Optimization of lipid nanoparticles for saRNA expression and cellular activation using a design-of-experiment approach. Mol. Pharm. 19, 1892–1905 (2022).
Google Scholar
Su, K. et al. Reformulating lipid nanoparticles for organ-targeted mRNA accumulation and translation. Nat. Commun. 15, 5659 (2024).
Google Scholar
Wang, C. et al. Blood–brain-barrier-crossing lipid nanoparticles for mRNA delivery to the central nervous system. Nat. Mater. 24, 1653–1663 (2025).
Google Scholar
Yamankurt, G. et al. Exploration of the nanomedicine-design space with high-throughput screening and machine learning. Nat. Biomed. Eng. 3, 318–327 (2019).
Google Scholar
Xu, Y. et al. LUMI-lab: a foundation model-driven autonomous platform enabling discovery of ionizable lipid designs for mRNA delivery. Cell 189, 1620–1635 (2026).
Xu, Y. et al. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery. Nat. Commun. 15, 6305 (2024).
Google Scholar
Wang, W. et al. Artificial intelligence-driven rational design of ionizable lipids for mRNA delivery. Nat. Commun. 15, 10804 (2024).
Google Scholar
Witten, J. et al. Artificial intelligence-guided design of lipid nanoparticles for pulmonary gene therapy. Nat. Biotechnol. 43, 1790–1799 (2025).
Li, B. et al. Accelerating ionizable lipid discovery for mRNA delivery using machine learning and combinatorial chemistry. Nat. Mater. 23, 1002–1008 (2024).
Google Scholar
Sengprasert, P., Kamenkit, O., Tanavalee, A. & Reantragoon, R. The immunological facets of chondrocytes in osteoarthritis: a narrative review. J. Rheumatol. 51, 13–24 (2024).
Aigner, T., Söder, S., Gebhard, P. M., McAlinden, A. & Haag, J. Mechanisms of disease: role of chondrocytes in the pathogenesis of osteoarthritis–structure, chaos and senescence. Nat. Clin. Pract. Rheumatol. 3, 391–399 (2007).
Google Scholar
Zheng, L., Zhang, Z., Sheng, P. & Mobasheri, A. The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritis. Ageing Res. Rev. 66, 101249 (2021).
Google Scholar
Madry, H. & Trippel, S. B. Efficient lipid-mediated gene transfer to articular chondrocytes. Gene Ther. 7, 286–291 (2000).
Google Scholar
Hamm, A., Krott, N., Breibach, I., Blindt, R. & Bosserhoff, A. K. Efficient transfection method for primary cells. Tissue Eng. 8, 235–245 (2002).
Google Scholar
Li, X., Shen, L., Deng, Z. & Huang, Z. New treatment for osteoarthritis: gene therapy. Precis. Clin. Med. 6, pbad014 (2023).
Google Scholar
Wang, Y., Wang, J., Cao, Z. & Barati Farimani, A. Molecular contrastive learning of representations via graph neural networks. Nat. Mach. Intell. 4, 279–287 (2022).
Google Scholar
Moriwaki, H., Tian, Y.-S., Kawashita, N. & Takagi, T. Mordred: a molecular descriptor calculator. J. Cheminform. 10, 4 (2018).
Google Scholar
McInnes, L., Healy, J., Saul, N. & Großberger, L. UMAP: uniform manifold approximation and projection. J. Open Source Softw. 3, 861 (2018).
Schwab, W. et al. Characterization of caveolins from human knee joint cartilage: expression of caveolin-1, -2, and -3 in chondrocytes and association with integrin β1. Histochem. Cell Biol. 113, 221–225 (2000).
Google Scholar
Wang, P., Zhu, F., Tong, Z. & Konstantopoulos, K. Response of chondrocytes to shear stress: antagonistic effects of the binding partners Toll-like receptor 4 and caveolin-1. FASEB J. 25, 3401–3415 (2011).
Google Scholar
Guan, F. et al. Tissue macrophages: origin, heterogenity, biological functions, diseases and therapeutic targets. Signal Transduct. Target. Ther. 10, 93 (2025).
Google Scholar
Gustafson, H. H., Holt-Casper, D., Grainger, D. W. & Ghandehari, H. Nanoparticle UPTAKE: THE PHAGOCYTE PROBLEM. Nano Today 10, 487–510 (2015).
Google Scholar
Madisen, L. et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat. Neurosci. 13, 133–140 (2010).
Google Scholar
Staahl, B. T. et al. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes. Nat. Biotechnol. 35, 431–434 (2017).
Google Scholar
Finn, J. D. et al. A single administration of CRISPR/Cas9 lipid nanoparticles achieves robust and persistent in vivo genome editing. Cell Rep. 22, 2227–2235 (2018).
Google Scholar
Yu, S. Y. et al. A luciferase reporter mouse model to optimize in vivo gene editing validated by lipid nanoparticle delivery of adenine base editors. Mol. Ther. 31, 1159–1166 (2023).
Google Scholar
Bedingfield, S. K. et al. Amelioration of post-traumatic osteoarthritis via nanoparticle depots delivering small interfering RNA to damaged cartilage. Nat. Biomed. Eng. 5, 1069–1083 (2021).
Google Scholar
Colazo, J. M. et al. siRNA conjugate with high albumin affinity and degradation resistance for delivery and treatment of arthritis in mice and guinea pigs. Nat. Biomed. Eng. 9, 1366–1383 (2025).
Google Scholar
Bedingfield, S. K. et al. Top-down fabricated microPlates for prolonged, intra-articular matrix metalloproteinase 13 siRNA nanocarrier delivery to reduce post-traumatic osteoarthritis. ACS Nano 15, 14475–14491 (2021).
Google Scholar
Hu, Q. & Ecker, M. Overview of MMP-13 as a promising target for the treatment of osteoarthritis. Int. J. Mol. Sci. 22, 1742 (2021).
Google Scholar
Wang, M. et al. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15, R5 (2013).
Google Scholar
Takaishi, H., Kimura, T., Dalal, S., Okada, Y. & D’Armiento, J. Joint diseases and matrix metalloproteinases: a role for MMP-13. Curr. Pharm. Biotechnol. 9, 47–54 (2008).
Google Scholar
Zenhausern, R. et al. Lipid nanoparticle screening in nonhuman primates with minimal loss of life. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02711-y (2025).
Kim, H. et al. Lipid nanoparticle-mediated mRNA delivery to CD34+ cells in rhesus monkeys. Nat. Biotechnol. 43, 1813–1820 (2025).
Charni-Natan, M. & Goldstein, I. Protocol for primary mouse hepatocyte isolation. STAR Protoc. 1, 100086 (2020).
Google Scholar
Gosset, M., Berenbaum, F., Thirion, S. & Jacques, C. Primary culture and phenotyping of murine chondrocytes. Nat. Protoc. 3, 1253–1260 (2008).
Google Scholar
Saeki, N. & Imai, Y. Isolation and culture of primary synovial macrophages and fibroblasts from murine arthritis tissue. J. Vis. Exp. 192, e65196 (2023).
Li, B. & Li, G. bowenli-lab/MOLEA: v1.0.0. Zenodo https://doi.org/10.5281/zenodo.18943783 (2026).
